Peter Orth

Person

Bronxville, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Factor XIIa inhibitors
- Patent number 11,014,920
- Issue date May 25, 2021
- Merck Sharp & Dohme Corp.
- Jacqueline D. Hicks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor XIIa inhibitors
- Patent number 10,875,851
- Issue date Dec 29, 2020
- Merck Sharp & Dohme Corp.
- Ashwin U. Rao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered anti-IL-23p19 antibodies
- Patent number 9,809,648
- Issue date Nov 7, 2017
- Merck Sharp & Dohme Corp.
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline anti-human IL-23p19 antibodies
- Patent number 9,803,010
- Issue date Oct 31, 2017
- Merck Sharp & Dohme Corp.
- Paul Reichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C.difficile toxin B CROP domain peptides, antibodies and complexes...
- Patent number 9,181,632
- Issue date Nov 10, 2015
- Merck Sharp & Dohme Corp.
- Nicholas Murgolo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinoxalines as inhibitors of fatty acid binding protein
- Patent number 8,889,683
- Issue date Nov 18, 2014
- Merck Sharp & Dohme Corp.
- Clifford Cheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of fatty acid binding protein (FABP)
- Patent number 8,815,875
- Issue date Aug 26, 2014
- Merck Sharp & Dohme Corp.
- Gerald W. Shipps
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of fatty acid binding protein (FABP)
- Patent number 8,759,357
- Issue date Jun 24, 2014
- Merck Sharp & Dohme Corp.
- Gerald W. Shipps
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal of human interferon alpha 2B in complex with zinc
- Patent number 8,679,472
- Issue date Mar 25, 2014
- Merck, Sharp & Dohme Corp.
- Paul Reichert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered anti-IL-23p19 antibodies
- Patent number 8,513,389
- Issue date Aug 20, 2013
- Merck Sharp & Dohme Corp.
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,879,890
- Issue date Feb 1, 2011
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified tumor necrosis factor-alpha converting enzyme and methods...
- Patent number 7,824,897
- Issue date Nov 2, 2010
- Schering Corp.
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered anti-IL-23 antibodies
- Patent number 7,807,160
- Issue date Oct 5, 2010
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified tumor necrosis factor-alpha converting enzyme and methods...
- Patent number 7,700,753
- Issue date Apr 20, 2010
- Schering Corporation
- Brian M. Beyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,687,527
- Issue date Mar 30, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,683,085
- Issue date Mar 23, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,652,020
- Issue date Jan 26, 2010
- Schering Corporation
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for identifying modified tumor necrosis factor-alpha conver...
- Patent number 7,529,628
- Issue date May 5, 2009
- Schering Corporation
- Brian M. Beyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,504,424
- Issue date Mar 17, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,488,745
- Issue date Feb 10, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,482,370
- Issue date Jan 27, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of an n231 mutant catalytic domain of ADAM33 and m...
- Patent number 7,285,408
- Issue date Oct 23, 2007
- Schering Corporation
- Peter Orth
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified tumor necrosis factor-alpha converting enzyme and methods...
- Patent number 7,138,264
- Issue date Nov 21, 2006
- Schering Corporation
- Brian M. Beyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Factor XIIa Inhibitors
- Publication number 20200262831
- Publication date Aug 20, 2020
- MERCK SHARP & DOHME CORP.
- Jacqueline D. Hicks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor XIIa Inhibitors
- Publication number 20190352294
- Publication date Nov 21, 2019
- MERCK SHARP & DOHME CORP.
- Ashwin U. Rao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE ANTI-HUMAN IL-23 ANTIBODIES
- Publication number 20150147337
- Publication date May 28, 2015
- MERCK SHARP & DOHME CORP.
- Paul Reichert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Engineered Anti-IL-23p19 Antibodies
- Publication number 20130122009
- Publication date May 16, 2013
- MERCK SHARP & DOHME CORP.
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ANTI-IL-23p19 ANTIBODIES
- Publication number 20130039916
- Publication date Feb 14, 2013
- Merck Sharpe & Dohme Corp.
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)
- Publication number 20120190696
- Publication date Jul 26, 2012
- Schering Corporation
- Gerald W. Shipps, JR.
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN
- Publication number 20120122837
- Publication date May 17, 2012
- CLIFFORD CHENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)
- Publication number 20110237575
- Publication date Sep 29, 2011
- Gerald W. Shipps, JR.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Engineered Anti-IL-23p19 Antibodies
- Publication number 20110142853
- Publication date Jun 16, 2011
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Engineered Anti-IL-23 Antibodies
- Publication number 20110002942
- Publication date Jan 6, 2011
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ANTI-IL-23P19 ANTIBODIES
- Publication number 20100272731
- Publication date Oct 28, 2010
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS...
- Publication number 20100184111
- Publication date Jul 22, 2010
- Schering Corporation
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20100145048
- Publication date Jun 10, 2010
- Schering Corporation
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED ANTI-IL-23P19 ANTIBODIES
- Publication number 20100111966
- Publication date May 6, 2010
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS...
- Publication number 20090221016
- Publication date Sep 3, 2009
- Schering Corporation
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090170875
- Publication date Jul 2, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED ANTI-IL-23 ANTIBODIES
- Publication number 20090156788
- Publication date Jun 18, 2009
- Schering Corporation
- Leonard G. Presta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090137586
- Publication date May 28, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090111803
- Publication date Apr 30, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20070219218
- Publication date Sep 20, 2007
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modified tumor necrosis factor-alpha converting enzyme and methods...
- Publication number 20070148669
- Publication date Jun 28, 2007
- Schering Corporation
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060276506
- Publication date Dec 7, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060252778
- Publication date Nov 9, 2006
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060205797
- Publication date Sep 14, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline form of the catalytic domain of ADAM33 and methods of u...
- Publication number 20040157309
- Publication date Aug 12, 2004
- Schering Corporation
- Peter Orth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Factor XIIa inhibitors

Factor XIIa inhibitors

Engineered anti-IL-23p19 antibodies

Crystalline anti-human IL-23p19 antibodies

C.difficile toxin B CROP domain peptides, antibodies and complexes...

Substituted quinoxalines as inhibitors of fatty acid binding protein

Inhibitors of fatty acid binding protein (FABP)

Inhibitors of fatty acid binding protein (FABP)

Crystal of human interferon alpha 2B in complex with zinc

Engineered anti-IL-23p19 antibodies

Compounds for the treatment of inflammatory disorders

Modified tumor necrosis factor-alpha converting enzyme and methods...

Engineered anti-IL-23 antibodies

Modified tumor necrosis factor-alpha converting enzyme and methods...

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Methods for identifying modified tumor necrosis factor-alpha conver...

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Crystalline form of an n231 mutant catalytic domain of ADAM33 and m...

Modified tumor necrosis factor-alpha converting enzyme and methods...

Patents Applicationslast 30 patents

Factor XIIa Inhibitors

Factor XIIa Inhibitors

CRYSTALLINE ANTI-HUMAN IL-23 ANTIBODIES

Engineered Anti-IL-23p19 Antibodies

ENGINEERED ANTI-IL-23p19 ANTIBODIES

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

INHIBITORS OF FATTY ACID BINDING PROTEIN

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

Engineered Anti-IL-23p19 Antibodies

Engineered Anti-IL-23 Antibodies

ENGINEERED ANTI-IL-23P19 ANTIBODIES

MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS...

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

ENGINEERED ANTI-IL-23P19 ANTIBODIES

MODIFIED TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AND METHODS...

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

ENGINEERED ANTI-IL-23 ANTIBODIES

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Compounds for the treatment of inflammatory disorders

Modified tumor necrosis factor-alpha converting enzyme and methods...

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Crystalline form of the catalytic domain of ADAM33 and methods of u...